Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product

scientific article published on 15 December 2008

Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1423-0410.2008.01138.X
P698PubMed publication ID19207166

P2093author name stringB Pignon
P Nguyen
C Tournois
J-J Lefrère
M-A Sevestre
S Daliphard
T Reix
F Vitry
J-C Capiod
P2860cites workStatistical methods for assessing agreement between two methods of clinical measurementQ26778461
Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbsQ31113638
Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometryQ36019443
Origin of endothelial progenitors in human postnatal bone marrowQ39737487
Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populationsQ46926506
P433issue3
P304page(s)256-265
P577publication date2008-12-15
P1433published inVox SanguinisQ15708866
P1476titleCharacterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product
P478volume96

Reverse relations

cites work (P2860)
Q27026719Autologous bone marrow cell therapy for peripheral arterial disease
Q57166884Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients
Q33873772CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine
Q27022590Cell-based interventions for therapeutic angiogenesis: review of potential cell sources
Q92970977Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Q47136650Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source.
Q34338454Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
Q38736561Growth factors for angiogenesis in peripheral arterial disease.
Q38266756Imaging techniques to evaluate cell therapy in peripheral artery disease: state of the art and clinical trials.
Q24187178Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia
Q24234480Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia
Q38599441Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder.
Q33693578Outgrowing endothelial and smooth muscle cells for tissue engineering approaches
Q26852080The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding

Search more.